Table 1.
Demographic data between fracture (VFF) and non-fracture group
| Characteristics | Whole cohort (n = 617) |
No fracture (n = 438) |
Vertebral fracture (n = 179) |
p Value | Youden criterion* | ||
|---|---|---|---|---|---|---|---|
| Value displayed in mean ± SDa | |||||||
| Age (year) | 68.52 ± 8.56 | 66.97 ± 8.32 | 72.31 ± 7.98 | < 0.01 | 65.00 | ||
| Height (cm) | 151.55 ± 5.83 | 152.13 ± 5.80 | 150.14 ± 5.67 | < 0.01 | 152.00 | ||
| Weight (kg) | 56.17 ± 9.91 | 56.29 ± 9.87 | 55.89 ± 10.03 | 0.654 | 58.80 | ||
| BMI (kg/m2) | 24.47 ± 4.18 | 24.35 ± 4.22 | 24.76 ± 4.08 | 0.258 | 24.49 | ||
| Value displayed in median (min, max)b | |||||||
| History of height loss (cm) | 1.0 (0, 9) | 0.5 (0, 6) | 1.5 (0, 9) | < 0.01 | 1.50 | ||
| BMD T-score L1–L4 | -1.7 (-5.6, 3.1) | -1.6 (-5.1, 2.6) | -1.9 (-5.6, 3.1) | 0.017 | -1.80 | ||
| BMD T-score femoral neck | -2.0 (-4.9, 1.4) | -1.9 (-4.4, 1.4) | -2.2 (-4.9, 0.4) | < 0.01 | -1.70 | ||
| BMD T-score total hip | -0.9 (-4.3, 2.7) | -0.8 (-4.3, 2.7) | -1.0 (-4.0, 1.4) | < 0.01 | -0.50 | ||
| Steroid usage n (%) | 2 (100%) | 1(0.2%) | 1 (0.6%) | 0.513+ | N/A | ||
aData was in normal distribution: the statistical difference was calculated by T-test
bData was not in normal distribution: the statistical difference was calculated by Wilcoxon rank-sum test
+Chi-square test
*Calculated from ROC analysis
Italics: significant level for area under the curve (AUC) = 0.05, N/A not applicable